Episode 119: AML Series, Pt 5 - AML Induction: Options for Upfront Therapy

Episode 119: AML Series, Pt 5 - AML Induction...

Up next

Episode 161: Career Development Series- Building a Career in Clinical Research

This week, we are so excited to share the third episode of our Career Development Series episodes, developed in partnership with The American Society of Hematology, The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidan ...  Show more

Episode 160: Head and Neck Cancer Series, Pt. 3 – Discussion with ENT

Throughout this series, we have discussed how multidisciplinary the management of head and neck cancer is and the critical role that our surgical colleagues play in the management of this disease. This week, we welcome Dr. Michael Topf, Associate Professor for Associate Professor ...  Show more

Recommended Episodes

Chapter 11: Hematology and Oncology (Part 7)
Crush Step 1: The Ultimate USMLE Step 1 Review

In the final episode from the Hematology and Oncology chapter of Crush Step 1, we discuss: - Myeloproliferative Disorders - Disorders of Heme Production - Pharmacologic Treatment Learn more about your ad choices. Visit megaphone.fm/adchoices 

254. Months of Monocytosis – An approach to CMML
The Intern At Work: Internal Medicine

Send us Fan MailIn this episode, we discuss the clinical presentation, work-up, and treatment of CMML. Our medicine minute discusses emerging evidence on the use of ruxolitinib for CMML treatment. Written by: Dr. Elliot Smith (Internal Medicine Resident)Reviewed by: Dr. Stephanie ...  Show more

Spotlight on Acute Myeloid Leukemia
Blood Podcast

In this Spotlight series episode on Acute Myeloid Leukemia, Blood Editor, Dr. Selina Luger interviews Drs. Laura Michaelis and Alexander Perl on their paper in the series titled “The fit older adult with acute myeloid leukemia: clinical challenges to providing evidence-based fron ...  Show more

Acute Myeloid Leukemia (AML) 2024 x Dr. Catherine Lai Part 2
Two Onc Docs

Today’s episode is an update on AML (acute myeloid leukemia). In Part 2 we discuss the treatment options for first-line, as well as relapsed/refractory disease. We are so honored to have Dr. Catherine Lai here with us who is Associate Professor and Physician Leader of the Leuk ...

  Show more